Empower Clinics Comes Out Of Stealth Mode With Big Growth And A Grand Plan To Restore Shareholder Value

AGORACOM Small Cap CEO Interviews

Empower Clinics is a healthcare company with a growing research and clinical trials division that is currently achieving early success in the Dallas and Los Angeles markets, including already being awarded its first clinical trial from a Global Fortune 500 Pharmaceutical Company.

But Empower is just getting started according to CEO Steven McAuley, who has come out of regulator mandated stealth mode to report very promising business growth to shareholders.

Specifically, while under cease trade, Empower has grown their active sites from 2 in the fall to 6 today - and Principal Investigators from 6 to 14 today. That foundation of doctors and medical offices opens the door to potential major contract wins from pharmaceutical companies that need speed and smarts from partners like Empower to get their clinical trials completed.

Empower’s timing couldn’t be better because Fortune Business Insights states the global Clinical Trials Market size is projected to reach USD 92.45 billion in 2030, driven by expanding pharmaceutical, biotechnology, and medical device R&D pipelines as developed G20 nations demographics get increasingly older. This positions Empower to play a pivotal role in this transformative era of healthcare.

Watch this powerful interview with CEO Steven McAuley and AGORACOM Founder George Tsiolis.